The Consortium of Multiple Sclerosis Centers
Strategic Alliance Partnership
Advancing the profession, navigating physicians through an evolving healthcare system
Latest from The Consortium of Multiple Sclerosis Centers
Clyde Markowitz: What is NEDA and How Does it Help Patient Care
As new treatments are developed for multiple sclerosis one of the questions has become how do you measure their success. A possible metric being developed is No Evidence of Disease Activity or NEDA.
Anthony Feinstein: Improving Treatment and Education of Depression and Cognition in Multiple Sclerosis
There is still much more to be learned about the effects of depression and cognitive impairment in patients with multiple sclerosis but there are steps being taken to address these issues and help better inform patients of the impact both can play in their lives.
Anthony Feinstein: Testing Cognition in Real World Situations
Patients diagnosed with multiple sclerosis may feel their cognitive abilities slip in their everyday lives but without the proper testing their level of impairment may not be properly diagnosed.
Anthony Feinstein from the University of Toronto: Taking a Closer Look at Depression in Multiple Sclerosis
Patients diagnosed with multiple sclerosis may develop depression as a result of the diagnosis but there is also research being done to show that depression can be part of the disease rather than as a result of it.
Maureen Mealy: Moving Treatment of NMO Forward
While the work being done to find a treatment for neuromyelitis optica is encouraging those in the field know they have not yet found a cure for the condition and that the agents being investigated will not help reverse the damage already done, which can be discouraging at times.
Maureen Mealy: Raising Awareness for a Rare Disease and Moving Treatment Forward
There are rare diseases and then there are ultra rare diseases. Neuromyelitis optica falls into the latter category but with a considerable amount of research behind it and a defined target to look at there has been success seen in finding treatments with more work being done every day.
Maureen Mealy from Johns Hopkins Medicine: New Treatments for Neuromyelitis Optica in the Pipeline
While there are no approved treatments currently for neuromyelitis optica there is a considerable amount of work being done to help patients with this rare condition in the future.
Megan Weigel from Baptist Neurology: Using Yoga in Multiple Sclerosis Treatment
At first glance, having patients with multiple sclerosis do yoga may seem unsafe and dangerous to their health. However, under the watch of a properly trained teacher and with careful monitoring this form of exercise has proven beneficial in even some of the most severe cases.
Clyde Markowitz From University of Pennsylvania: Moving Multiple Sclerosis Treatment Forward for All
It was not that long ago when doctors would sometimes not discuss the diagnosis of multiple sclerosis with their patients. Now not only is it a condition they can diagnose but treatment is also progressing by leaps and bounds.
Tweets by @mscare
Affordable Care Act
PHYSICIAN'S MONEY DIGEST >
Affiliated Websites >
American Journal of Managed Care
Cure Hepatitis C
Specialty Pharmacy Times
Rare Disease Report
MD Magazine Resources
Terms & Conditions
Copyright MD Magazine 2006-2017 Intellisphere, LLC. All Rights Reserved.